• Movie

    Click here for the video of Kyoto.

  • Important Dates:

    October 18, 2016
    Abstract Submission Open

    December 1, 2016
    Registration Open
    Hotel Reservation Open

    February 28, 2017
    March 14, 2017

    Deadline Abstract Submission

    April 30, 2017
    Notification Abstract/Poster Presentations

    May 21, 2017
    Deadline Late-Breaking Abstract Submission

    June 30, 2017
    Deadline Early Bird Registration

    August 31, 2017
    Deadline Advanced Registration

Scientific Program (Tentative Program)

Opening Joint Symposium

Sunday, September 24  14:00-16:40 Main Hall
IATDMCT-JSTDM Joint Symposium-Expansion and Evolution of TDM and CT-

IATDMCT JSTDM YS Joint Session

Sunday, September 24  14:30-16:40 Room D

Plenary Lectures

  • Monday, September 25
    Mass spectrometry for research and clinical implementation of TDM&CT.
    Hans H. Maurer (Saarland University, Germany)
  • Tuesday, September 26
    Therapeutic drug monitoring is needed for monoclonal antibodies.
    Diane Mould (Projections Research, USA)
  • Wednesday, September 27
    Circulating cell-free DNA as a new tool for personalized pharmacotherapy.
    Michael Oellerich (University Medicine Göttingen, Germany)

Symposia (Planned)

  • Dried blood spot analysis: Are we ready for implementation?
  • TDM for multi-drug resistant organisms
  • Applying TDM to HIV and TB therapy
  • Pharmacometric approach on anti-infective medications
  • TDM for central nervous system drugs
  • TDM for cardiovascular and endocrine diseases
  • Biomarkers and TDM of Immunosuppressive drugs
  • TDM for the management of cancer therapy
  • TDM of 5-FU
  • Progress of TDM for hematopoietic stem cell transplantation
  • Assay and screening for drugs in clinical and forensic toxicology
  • Herbal Medicines: Toxicity, interactions and interferences in TDM
  • Drug exposure during pregnancy and lactation
  • Debate session: Generics
  • TDM in Asia
  • Young Scientist Symposium

Post Congress Symposium

Thursday, September 28  9:00-16:00
Theme  “Guidelines and Consensus Documents for TDM”

  1. Therapeutic Drug Monitoring of Everolimus
    Immunosuppressive Drugs Scientific Committee of the IATDMCT
  2. Guidelines on Therapeutic Drug Monitoring of Immunosuppressive Drugs Used in Organ Transplantation
    Japanese Society of Therapeutic Drug Monitoring (JSTDM)
  3. Analytical methods of Measurement for Immunosuppressive Drug Concentrations
    Immunosuppressive Drugs Scientific Committee of the IATDMCT
  4. Dried blood spot (DBS) sampling and analysis guideline
    Alternative Sampling Strategies Committee of the IATDMCT
  5. Guidelines for Therapeutic Drug Monitoring of Cardiovascular Drugs
    Japanese Society of Therapeutic Drug Monitoring (JSTDM)
  6. Draft Guideline on TDM of 5-FU,
    TDM in Oncology Scientific Committee of the IATDMCT
  7. Busulfan TDM: Current consensus and discrepancy,
    TDM in Oncology Scientific Committee of the IATDMCT
  8. Concept paper on imatinib TDM
    TDM in Oncology Scientific Committee of the IATDMCT
  9. Guidelines for Therapeutic Drug Monitoring of Antiepileptic Drugs
    Japanese Society of Therapeutic Drug Monitoring (JSTDM)

And the following programs are also planned now:
-Morning Roundtables          -Industry Workshops 
-General Oral Presentations     -Poster Sessions
-YS programs as YS Lunch, YS Night, and so on.